{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:59:41Z","timestamp":1791809981481,"version":"4.3.4"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>This study evaluated the efficacy of an optimized immunosuppressive regimen, including a higher dose of anti-CD154 monoclonal antibody (TNX-1500), in prolonging graft survival in pig-to-baboon kidney xenotransplantation. Despite advances in genetic engineering of organ-source pigs and immunosuppressive regimens, we report that the development of nephrotic-range proteinuria remains a significant problem.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We assessed the TNX-1500-based immunosuppressive regimen in 9 baboon recipients of gene-edited pig kidney transplants. The regimen included induction with antithymocyte globulin, anti-CD20 monoclonal antibody (rituximab), and C1 esterase inhibitor, and maintenance with TNX-1500, rapamycin, methylprednisolone, and anti-interleukin-6 receptor blockade (tocilizumab).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Although an increased dose of TNX-1500 of 30 mg\/kg (higher dose, n\u2005=\u20056) versus 20 mg\/kg (lower dose, n\u2005=\u20053) improved overall survival (median 214 versus 86 d;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05), 4 of 9 baboons (including 3 with higher dose) developed persistent nephrotic-range proteinuria. The histopathology of these 4 grafts revealed focal glomerular thrombotic microangiopathy (4\/4), transplant glomerulopathy (3\/4), focal segmental glomerulosclerosis (2\/4), and\/or membranous nephropathy (1\/4) but no definitive features of rejection. Proteinuria was associated with decreased serum albumin and, very importantly, with loss of TNX-1500 in the urine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Despite the efficacy of the immunosuppressive regimen, we suggest that proteinuria may lead to inadequate immunosuppressive therapy through loss of the therapeutic antibody, thus increasing the risk of rejection. Further research is needed to develop strategies to prevent this complication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005508","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:00:38Z","timestamp":1759809638000},"page":"e141-e153","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Proteinuria Remains a Significant Hurdle to Successful Pig Kidney Xenotransplantation Despite an Effective Immunosuppressive Regimen"],"prefix":"10.1097","volume":"110","author":[{"given":"Kohei","family":"Kinoshita","sequence":"first","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Maenaka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Terashita","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy A.","family":"Rosales","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gweneth Eliza","family":"Lavalla","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Habibabady","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ayares","sequence":"additional","affiliation":[{"name":"Revivicor, Blacksburg, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Lederman","sequence":"additional","affiliation":[{"name":"Tonix Pharmaceuticals, Chatham, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Colvin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Pierson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.C.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital\/Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation.","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"e12293","DOI":"10.1111\/xen.12293","article-title":"Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts.","volume":"24","author":"Iwase","year":"2017","journal-title":"Xenotransplantation"},{"key":"R3-20260119","doi-asserted-by":"crossref","first-page":"e12516","DOI":"10.1111\/xen.12516","article-title":"Justification of specific genetic modifications in pigs for clinical organ xenotransplantation.","volume":"26","author":"Cooper","year":"2019","journal-title":"Xenotransplantation"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"e12859","DOI":"10.1111\/xen.12859","article-title":"Novel factors potentially initiating acute antibody-mediated rejection in pig kidney xenografts despite an efficient immunosuppressive regimen.","volume":"31","author":"Kinoshita","year":"2024","journal-title":"Xenotransplantation"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/TP.0000000000003622","article-title":"What therapeutic regimen will be optimal for initial clinical trials of pig organ transplantation?","volume":"105","author":"Bikhet","year":"2021","journal-title":"Transplantation"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/TP.0000000000004097","article-title":"Advancing xenotransplantation to the clinic: how relevant is the pig-to-nonhuman primate kidney transplantation model today?","volume":"106","author":"Cooper","year":"2022","journal-title":"Transplantation"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.3389\/ti.2024.13942","article-title":"The evolution of immunosuppressive therapy in pig-to-nonhuman primate organ transplantation.","volume":"37","author":"Sanatkar","year":"2025","journal-title":"Transpl Int"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00062752-199603010-00012","article-title":"The central role of the CD40-ligand and CD40 pathway in T-lymphocyte-mediated differentiation of B lymphocytes.","volume":"3","author":"Lederman","year":"1996","journal-title":"Curr Opin Hematol"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ajt.2023.03.025","article-title":"TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival.","volume":"23","author":"Miura","year":"2023","journal-title":"Am J Transplant"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ajt.2023.03.022","article-title":"TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival.","volume":"23","author":"Lassiter","year":"2023","journal-title":"Am J Transplant"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"eadf6376","DOI":"10.1126\/scitranslmed.adf6376","article-title":"The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates.","volume":"15","author":"Anwar","year":"2023","journal-title":"Sci Transl Med"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ajt.16780","article-title":"Kidney transplantation from triple-knockout pigs expressing multiple human proteins in cynomolgus macaques.","volume":"22","author":"Ma","year":"2022","journal-title":"Am J Transplant"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases.","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajt.2023.08.016","article-title":"De novo membranous nephropathy in a pig-to-baboon kidney xenograft: a new xenograft glomerulopathy.","volume":"24","author":"Rosales","year":"2024","journal-title":"Am J Transplant"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2008.01.016","article-title":"Quantitative determination of humanized monoclonal antibody rhuMAb2H7 in cynomolgus monkey serum using a generic immunoglobulin pharmacokinetic (GRIP) assay.","volume":"335","author":"Yang","year":"2008","journal-title":"J Immunol Methods"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/TP.0000000000001258","article-title":"Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in CD154-treated monkeys.","volume":"101","author":"Azimzadeh","year":"2017","journal-title":"Transplantation"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the Banff classification of renal allograft pathology.","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"key":"R18-20260119","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/00007890-200006150-00013","article-title":"High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.","volume":"69","author":"B\u00fchler","year":"2000","journal-title":"Transplantation"},{"key":"R19-20260119","doi-asserted-by":"crossref","first-page":"8415205","DOI":"10.1155\/2017\/8415205","article-title":"The role of costimulation blockade in solid organ and islet xenotransplantation.","volume":"2017","author":"Samy","year":"2017","journal-title":"J Immunol Res"},{"key":"R20-20260119","doi-asserted-by":"crossref","first-page":"861471","DOI":"10.3389\/fimmu.2022.861471","article-title":"The Inhibition of CD40\/CD154 costimulatory signaling in the prevention of renal transplant rejection in nonhuman primates: a systematic review and meta analysis.","volume":"13","author":"Perrin","year":"2022","journal-title":"Front Immunol"},{"key":"R21-20260119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/72162","article-title":"Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand.","volume":"6","author":"Kawai","year":"2000","journal-title":"Nat Med"},{"key":"R22-20260119","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/IMT.15.54","article-title":"Update on CD40 and CD154 blockade in transplant models.","volume":"7","author":"Zhang","year":"2015","journal-title":"Immunotherapy"},{"key":"R23-20260119","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/imt.15.1","article-title":"Novel insights into anti-CD40\/CD154 immunotherapy in transplant tolerance.","volume":"7","author":"Pinelli","year":"2015","journal-title":"Immunotherapy"},{"key":"R24-20260119","doi-asserted-by":"crossref","first-page":"e12640","DOI":"10.1111\/xen.12640","article-title":"Immunosuppressive and metabolic agents that influence allo- and xenograft survival by in vivo expansion of T regulatory cells.","volume":"27","author":"Zhao","year":"2020","journal-title":"Xenotransplantation"},{"key":"R25-20260119","doi-asserted-by":"crossref","first-page":"20701","DOI":"10.1073\/pnas.1105500108","article-title":"Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40\/CD154 blockade.","volume":"108","author":"Ferrer","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-20260119","doi-asserted-by":"crossref","first-page":"e12802","DOI":"10.1111\/xen.12802","article-title":"The case for the therapeutic use of mechanistic\/mammalian target of rapamycin (mTOR) inhibitors in xenotransplantation.","volume":"30","author":"Maenaka","year":"2023","journal-title":"Xenotransplantation"},{"key":"R27-20260119","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1111\/ajt.16459","article-title":"Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: a randomized controlled trial.","volume":"21","author":"Chandran","year":"2021","journal-title":"Am J Transplant"},{"key":"R28-20260119","doi-asserted-by":"crossref","first-page":"156897","DOI":"10.1016\/j.cyto.2025.156897","article-title":"Inhibition of inflammation by IL-6 blockade in xenotransplantation.","volume":"189","author":"Iwanczyk","year":"2025","journal-title":"Cytokine"},{"key":"R29-20260119","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.immuni.2024.05.023","article-title":"The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program.","volume":"57","author":"Burton","year":"2024","journal-title":"Immunity"},{"key":"R30-20260119","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nm1172","article-title":"Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue.","volume":"11","author":"Yamada","year":"2005","journal-title":"Nat Med"},{"key":"R31-20260119","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/tri.13273","article-title":"Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation\u2014an experimental study.","volume":"31","author":"Rivard","year":"2018","journal-title":"Transpl Int"},{"key":"R32-20260119","doi-asserted-by":"crossref","first-page":"e12708","DOI":"10.1111\/xen.12708","article-title":"Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation.","volume":"28","author":"Takeuchi","year":"2021","journal-title":"Xenotransplantation"},{"key":"R33-20260119","doi-asserted-by":"crossref","first-page":"546039","DOI":"10.1155\/2012\/546039","article-title":"Understanding the mechanisms of proteinuria: therapeutic implications.","volume":"2012","author":"Toblli","year":"2012","journal-title":"Int J Nephrol"},{"key":"R34-20260119","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.kint.2023.11.022","article-title":"A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence.","volume":"105","author":"Shirai","year":"2024","journal-title":"Kidney Int"},{"key":"R35-20260119","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1038\/s41467-024-47679-6","article-title":"Consistent survival in consecutive cases of life-supporting porcine kidney xenotransplantation using 10GE source pigs.","volume":"15","author":"Eisenson","year":"2024","journal-title":"Nat Commun"},{"key":"R36-20260119","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00467-015-3120-8","article-title":"Pharmacokinetics of rituximab in a pediatric patient with therapy-resistant nephrotic syndrome.","volume":"30","author":"Counsilman","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"R37-20260119","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R38-20260119","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1060028018803587","article-title":"Rituximab exhibits altered pharmacokinetics in patients with membranous nephropathy.","volume":"53","author":"Fogueri","year":"2019","journal-title":"Ann Pharmacother"},{"key":"R39-20260119","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2215\/CJN.0000000000000145","article-title":"Proteinuria and exposure to eculizumab in atypical hemolytic uremic syndrome.","volume":"18","author":"Ter Avest","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"R40-20260119","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan.","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J Exp Med"},{"key":"R41-20260119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40262-012-0027-4","article-title":"Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.","volume":"52","author":"Dostalek","year":"2013","journal-title":"Clin Pharmacokinet"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:00:15Z","timestamp":1768834815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005508","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}